EndPoint: Alek Safarian
24 June 2011 | Joanne Payne Scrip Clinical Research
Lupin CEO eying Europe, active in M&A space Is the world in better shape than it's ever been? 5AM, New York funds part of small wave of venture capital What next for Sanofi Dengue vaccine?
Other Features & Analysis
Medtech VCs: assessing potential return on investment INTERVIEW: Through the eyes of Alcon Vision Care's head of R and D Telehealth: overcoming adoption hurdles – the French approach Strategic Strigini and the European endeavor